Almac and TTP Labtech have formed an alliance in the field of fluorescence lifetime (FLT) technology to provide enhanced screening performance. The alliance aims to provide customers with access to a broad range of biological applications coupled with the next generation of microplate reader technology.   According to the companies, FLT as a reading modality offers a robust, antibody-free, homogeneous assay platform that enables the user to avoid interference from fluorescent compounds within a ...